Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Huang T-, Renuse S, Pinto S, Kumar P, Yang Y, Chaerkady R, et al. Identification of miR-145 targets through an integrated omics analysis. Mol Biosyst. 2015;11(1):197-207.

Kim GS, Yang L, Zhang G, Zhao H, Selim M, McCullough LD, et al. Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nat Commun. 2015;6:7893.

Solomon JP, Hansel DE. Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates. Adv Anat Pathol. 2015;22(2):102-12.

Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, et al. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015;126(2):160-6.

Brown M, Chinnaiyan A, Farsetti A, Livingston DM, Loda M, Schuele R, et al. 26th Pezcoller symposium: cancers driven by hormones. Cancer Res. 2015;75(7):1177-80.

Trasino SE, Tang X-, Jessurun J, Gudas LJ. Obesity Leads to Tissue, but not Serum Vitamin A Deficiency. Sci Rep. 2015;5:15893.

Ma S-, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, et al. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. J Clin Invest. 2015;125(1):304-15.

Wang H, Yu C, Gao X, Welte T, Muscarella AM, Tian L, et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015;27(2):193-210.

Pagan JK, Marzio A, Jones MJ, Saraf A, Jallepalli PV, Florens L, et al. Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing. Nat Cell Biol. 2015;17(1):31-43.

Gordon JK, Martyanov V, Magro C, Wildman HF, Wood TA, Huang W-, et al. Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis Res Ther. 2015;17:213.